Medistim ASA (FRA:MD1)

Germany · Delayed Price · Currency is EUR

21.70

+0.30 (1.40%)

Last updated: Dec 3, 2025, 8:01 AM CET

78.60% (1Y)

Market Cap	396.03M
Revenue (ttm)	56.51M
Net Income (ttm)	12.15M
Shares Out	n/a
EPS (ttm)	0.66
PE Ratio	32.59
Forward PE	28.73
Dividend	0.51 (2.44%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	65
Open	21.70
Previous Close	21.40
Day's Range	21.70 - 21.70
52-Week Range	12.15 - 24.40
Beta	n/a
RSI	53.28
Earnings Date	Apr 9, 2026

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1984

Employees 154

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol MD1

Full Company Profile

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK Financial Statements

News

There is no news available yet.